Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > SONA ROCKET example for VXL

<< Previous

Bullboard Posts

Next >>

Comment by bligickaon Jul 04, 2020 6:24am

81 Views

Post# 31223519

RE:SONA ROCKET example for VXL

Sona has the advantage of a small float of only 60 million ....unfortunately Vaxil will have more than triple that with over 200 million once this ridiculous pp is completed . .....

<< Previous

Bullboard Posts

Next >>

Gold, growth and sustainability in focus for Mandalay Resources